Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Molluscum 2025
Description
The transcript discusses the prevalence and epidemiology of molluscum contagiosum, a common viral skin infection primarily affecting children. The poxvirus, which can spread through physical contact and contaminated surfaces, sees bimodal peaks in incidence among toddlers and school-aged children, particularly during swimming activities. It can also lead to secondary infections and complications in patients with atopic dermatitis. The presentation highlights the slow natural clearance of the virus in immunocompetent individuals and addresses barriers to treatment, including pediatricians often recommending watchful waiting. Furthermore, advancements in treatment options, including two new FDA-approved medications, are outlined. The discussion emphasizes the physical and psychological impact of molluscum on affected children and their families. Experts stress the importance of addressing parental concerns regarding contagion and treatment while acknowledging the need for improved communication and management strategies in pediatric settings.
View moreConclusions
- Molluscum contagiosum is a common viral skin infection caused by a double-stranded DNA pox virus, predominantly affecting children.
- The infection shows bimodal peaks, with significant incidence in toddlers and school-aged children, and it can also manifest as a sexually transmitted infection in adolescents.
- There is a correlation between molluscum and atopic dermatitis, with approximately 30% of cases presenting in patients with eczema.
- Molluscum can trigger inflammatory skin reactions such as molluscum dermatitis and exacerbate existing atopic dermatitis.
- The natural clearance of molluscum can take 12 to 18 months, with a notable portion of cases persisting for over two years, especially in patients with atopic conditions.
- Contagion typically occurs through skin-to-skin contact, shared personal items, and cohabitation, with swimming pools being a significant environmental factor for transmission.
- Treatment options include cryotherapy, curettage, and topical agents, but many pediatric patients are reluctant to undergo painful procedures due to self-consciousness about the lesions.
- Parents commonly express clinical concern due to its disfiguring nature, affecting children's social dynamics and parental anxiety about potential spread to siblings.
- Recent research has led to the development of improved therapies for molluscum contagiosum, with indications it can now be more effectively managed in clinical practice.
- Basdag H. Pediatrics Dermatol. 2015; 32: 353;
- Dohil M. JAAD. 54:47;
- McCollum AM. PLoS One. 2014; 9: e103419;
- Silverberg NB. Cutis. 2018; 102:191;
- Berger E. JAMA Dermatol. 2012; 148:1257;
- Luke JD. Pediatrics. 2010; 125:0-5.
- Arora N. Cureus. 2024 Jul Patient 4; 16(7):e63932.
- O'Connell C. Pediatr Dermatol. 2008; 25:553.
- Eichenfield LF, Siegfried E, Kwong P, et al. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials. JAMA Dermatol. 2020; 156(12):1315-1323.
- Browning JC, Enloe C, Cartwright M, et al. Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. Published online July 13, 2022. doi:10.1001/jamadermatol.2022.2721.
- Colasanti M, et al. IUBMB Life. 1999; 48(1):25-31.
- Burrell CJ, et al. Chapter 16 - Poxviruses. In: Fenner and White's Medical Virology. 5th ed. Academic Press; 2016:229-236.
- Randall CMH, et al. J Immunol. 2012; 188(5):2371-2379.
- Tripathi P, et al. Indian J Biochem Biophys. 2007; 44(5):310-319.